Analgesic efficacy of tramadol/acetaminophen and propoxyphene/acetaminophen for relief of postoperative wound pain

Feng Sheng Lin, Wen Ying Lin, Chia Hsin Lai, Chien Yu Chen, Chih Peng Lin, Tzu Fu Lin, Wei Zen Sun

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

Background/purpose: Weak opioid combined with acetaminophen (APAP) has been proven to provide better analgesic efficacy and cause fewer complications than either drug alone. However, there are questions about whether different opioids, tramadol and propoxyphene, provide similar efficacy or safety. Thus, we investigated Ultracet (37.5 mg tramadol/325 mg APAP) and Depain-X (65 mg propoxyphene/650 mg APAP). The primary aims of this study were to compare the analgesic efficacy and adverse effects of single-dose oral Ultracet versus Depain-X in acute postoperative pain. Materials and methods: This was a randomized, open-label, active-controlled parallel study on patients with postsurgical pain. Sixty patients who sustained moderate postsurgical pain (visual analog scale 33 cm) after undergoing implantation of venous access were randomized to two groups to receive either Ultracetor Depain-X for postoperative analgesia. Assessment items included pain intensity and pain relief ratings at the first 4 hours, and adverse events. Results: There were initially 107 patients who were enrolled in this trial, but up to 45 (42.1%) of them were withdrawn during the study. In these 62 patients who complied with treatment (Ultracet: Depain-X = 29: 33), pain relief scale indicated that Ultracet could provide a better analgesic effect than Depain-X provided at1 hour (p <0.05). At 4 hours, the pain score in the Ultracet group was significantly lower than that in the Depain-X group (p <0.05). Adverse events, such as drowsiness, dizziness, and skin itching did not differ in both groups. Conclusion: Among patients with mild to moderate postoperative wound pain, single-dose Ultracet can provide slightly better analgesic efficacy than Depain-X in terms of onset and duration. Depain-X is no longer marketed in Europe, America, Taiwan and other countries, therefore, Ultracet can serve as a good substitute for treating postoperative pain.

Original languageEnglish
Pages (from-to)49-53
Number of pages5
JournalActa Anaesthesiologica Taiwanica
Volume50
Issue number2
DOIs
Publication statusPublished - Jun 2012

Fingerprint

Tramadol
Acetaminophen
Postoperative Pain
Analgesics
Wounds and Injuries
Pain
Dextropropoxyphene
Opioid Analgesics
Sleep Stages
Acute Pain
Dizziness
Pain Measurement
Pruritus
acetaminophen, dextropropoxyphene, drug combination
Ultracet
Taiwan
Analgesia
Safety
Skin
Pharmaceutical Preparations

Keywords

  • acetaminophen
  • pain, postoperative
  • tramadol

ASJC Scopus subject areas

  • Anesthesiology and Pain Medicine

Cite this

Analgesic efficacy of tramadol/acetaminophen and propoxyphene/acetaminophen for relief of postoperative wound pain. / Lin, Feng Sheng; Lin, Wen Ying; Lai, Chia Hsin; Chen, Chien Yu; Lin, Chih Peng; Lin, Tzu Fu; Sun, Wei Zen.

In: Acta Anaesthesiologica Taiwanica, Vol. 50, No. 2, 06.2012, p. 49-53.

Research output: Contribution to journalArticle

Lin, Feng Sheng ; Lin, Wen Ying ; Lai, Chia Hsin ; Chen, Chien Yu ; Lin, Chih Peng ; Lin, Tzu Fu ; Sun, Wei Zen. / Analgesic efficacy of tramadol/acetaminophen and propoxyphene/acetaminophen for relief of postoperative wound pain. In: Acta Anaesthesiologica Taiwanica. 2012 ; Vol. 50, No. 2. pp. 49-53.
@article{02e14e930df846d0b68daf448eabea37,
title = "Analgesic efficacy of tramadol/acetaminophen and propoxyphene/acetaminophen for relief of postoperative wound pain",
abstract = "Background/purpose: Weak opioid combined with acetaminophen (APAP) has been proven to provide better analgesic efficacy and cause fewer complications than either drug alone. However, there are questions about whether different opioids, tramadol and propoxyphene, provide similar efficacy or safety. Thus, we investigated Ultracet (37.5 mg tramadol/325 mg APAP) and Depain-X (65 mg propoxyphene/650 mg APAP). The primary aims of this study were to compare the analgesic efficacy and adverse effects of single-dose oral Ultracet versus Depain-X in acute postoperative pain. Materials and methods: This was a randomized, open-label, active-controlled parallel study on patients with postsurgical pain. Sixty patients who sustained moderate postsurgical pain (visual analog scale 33 cm) after undergoing implantation of venous access were randomized to two groups to receive either Ultracetor Depain-X for postoperative analgesia. Assessment items included pain intensity and pain relief ratings at the first 4 hours, and adverse events. Results: There were initially 107 patients who were enrolled in this trial, but up to 45 (42.1{\%}) of them were withdrawn during the study. In these 62 patients who complied with treatment (Ultracet: Depain-X = 29: 33), pain relief scale indicated that Ultracet could provide a better analgesic effect than Depain-X provided at1 hour (p <0.05). At 4 hours, the pain score in the Ultracet group was significantly lower than that in the Depain-X group (p <0.05). Adverse events, such as drowsiness, dizziness, and skin itching did not differ in both groups. Conclusion: Among patients with mild to moderate postoperative wound pain, single-dose Ultracet can provide slightly better analgesic efficacy than Depain-X in terms of onset and duration. Depain-X is no longer marketed in Europe, America, Taiwan and other countries, therefore, Ultracet can serve as a good substitute for treating postoperative pain.",
keywords = "acetaminophen, pain, postoperative, tramadol",
author = "Lin, {Feng Sheng} and Lin, {Wen Ying} and Lai, {Chia Hsin} and Chen, {Chien Yu} and Lin, {Chih Peng} and Lin, {Tzu Fu} and Sun, {Wei Zen}",
year = "2012",
month = "6",
doi = "10.1016/j.aat.2012.05.009",
language = "English",
volume = "50",
pages = "49--53",
journal = "Asian Journal of Anesthesiology",
issn = "2468-824X",
publisher = "Elsevier Taiwan LLC",
number = "2",

}

TY - JOUR

T1 - Analgesic efficacy of tramadol/acetaminophen and propoxyphene/acetaminophen for relief of postoperative wound pain

AU - Lin, Feng Sheng

AU - Lin, Wen Ying

AU - Lai, Chia Hsin

AU - Chen, Chien Yu

AU - Lin, Chih Peng

AU - Lin, Tzu Fu

AU - Sun, Wei Zen

PY - 2012/6

Y1 - 2012/6

N2 - Background/purpose: Weak opioid combined with acetaminophen (APAP) has been proven to provide better analgesic efficacy and cause fewer complications than either drug alone. However, there are questions about whether different opioids, tramadol and propoxyphene, provide similar efficacy or safety. Thus, we investigated Ultracet (37.5 mg tramadol/325 mg APAP) and Depain-X (65 mg propoxyphene/650 mg APAP). The primary aims of this study were to compare the analgesic efficacy and adverse effects of single-dose oral Ultracet versus Depain-X in acute postoperative pain. Materials and methods: This was a randomized, open-label, active-controlled parallel study on patients with postsurgical pain. Sixty patients who sustained moderate postsurgical pain (visual analog scale 33 cm) after undergoing implantation of venous access were randomized to two groups to receive either Ultracetor Depain-X for postoperative analgesia. Assessment items included pain intensity and pain relief ratings at the first 4 hours, and adverse events. Results: There were initially 107 patients who were enrolled in this trial, but up to 45 (42.1%) of them were withdrawn during the study. In these 62 patients who complied with treatment (Ultracet: Depain-X = 29: 33), pain relief scale indicated that Ultracet could provide a better analgesic effect than Depain-X provided at1 hour (p <0.05). At 4 hours, the pain score in the Ultracet group was significantly lower than that in the Depain-X group (p <0.05). Adverse events, such as drowsiness, dizziness, and skin itching did not differ in both groups. Conclusion: Among patients with mild to moderate postoperative wound pain, single-dose Ultracet can provide slightly better analgesic efficacy than Depain-X in terms of onset and duration. Depain-X is no longer marketed in Europe, America, Taiwan and other countries, therefore, Ultracet can serve as a good substitute for treating postoperative pain.

AB - Background/purpose: Weak opioid combined with acetaminophen (APAP) has been proven to provide better analgesic efficacy and cause fewer complications than either drug alone. However, there are questions about whether different opioids, tramadol and propoxyphene, provide similar efficacy or safety. Thus, we investigated Ultracet (37.5 mg tramadol/325 mg APAP) and Depain-X (65 mg propoxyphene/650 mg APAP). The primary aims of this study were to compare the analgesic efficacy and adverse effects of single-dose oral Ultracet versus Depain-X in acute postoperative pain. Materials and methods: This was a randomized, open-label, active-controlled parallel study on patients with postsurgical pain. Sixty patients who sustained moderate postsurgical pain (visual analog scale 33 cm) after undergoing implantation of venous access were randomized to two groups to receive either Ultracetor Depain-X for postoperative analgesia. Assessment items included pain intensity and pain relief ratings at the first 4 hours, and adverse events. Results: There were initially 107 patients who were enrolled in this trial, but up to 45 (42.1%) of them were withdrawn during the study. In these 62 patients who complied with treatment (Ultracet: Depain-X = 29: 33), pain relief scale indicated that Ultracet could provide a better analgesic effect than Depain-X provided at1 hour (p <0.05). At 4 hours, the pain score in the Ultracet group was significantly lower than that in the Depain-X group (p <0.05). Adverse events, such as drowsiness, dizziness, and skin itching did not differ in both groups. Conclusion: Among patients with mild to moderate postoperative wound pain, single-dose Ultracet can provide slightly better analgesic efficacy than Depain-X in terms of onset and duration. Depain-X is no longer marketed in Europe, America, Taiwan and other countries, therefore, Ultracet can serve as a good substitute for treating postoperative pain.

KW - acetaminophen

KW - pain, postoperative

KW - tramadol

UR - http://www.scopus.com/inward/record.url?scp=84863722417&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84863722417&partnerID=8YFLogxK

U2 - 10.1016/j.aat.2012.05.009

DO - 10.1016/j.aat.2012.05.009

M3 - Article

C2 - 22769857

AN - SCOPUS:84863722417

VL - 50

SP - 49

EP - 53

JO - Asian Journal of Anesthesiology

JF - Asian Journal of Anesthesiology

SN - 2468-824X

IS - 2

ER -